Zdanowski Michael (0001845662)

Mailing Address C/O TALARIS THERAPEUTICS, INC. 93 WORCESTER STREET, SUITE 120 WELLESLEY MA 02481 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Talaris Therapeutics, Inc. Current Name:Tourmaline Bio, Inc. 0001827506 2021-05-06 officer: Chief Technology Officer

Items 1 - 6

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2023-02-01		Talaris Therapeutics, Inc.	4	A-Award	--D	150000.0000	150000.0000	1	0001827506	Stock Option (Right to Buy)
A	2023-02-01		Talaris Therapeutics, Inc.	4	A-Award	--D	150000.0000	150000.0000	2	0001827506	Stock Appreciation Right
A	2022-09-10		Talaris Therapeutics, Inc.	4	A-Award	--D	120000.0000	121470.0000	1	0001827506	Common Stock
A	2022-02-01		Talaris Therapeutics, Inc.	4	A-Award	--D	200000.0000	200000.0000	2	0001827506	Stock Option (Right to Buy)
A	2021-12-31	2021-12-31	Talaris Therapeutics, Inc.	4	A-Award	--D	1470.0000	1470.0000	1	0001827506	Common Stock
-	-		Talaris Therapeutics, Inc.	3	-	--D			1	0001827506	Stock Option (Right to Buy)

http://www.sec.gov/cgi-bin/own-disp

---